Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or β-blockers and the risk of atherosclerosis

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: To our knowledge, there are no prior studies which investigate whether there is a drug–gene interaction between the three genes involved in the renin–angiotensin system and ACE-inhibitor therapy or β-blocker therapy with these subclinical measurements of ath...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schelleman, H, Klungel, O H, Witteman, J C M, Hofman, A, van Duijn, C M, de Boer, A, Stricker, B H CH
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2007
Assuntos:
Pharmacogenetics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2000614/
https://ncbi.nlm.nih.gov/pubmed/17298481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2007.02848.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados